Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression (Q90337868)
Jump to navigation
Jump to search
scientific article published on 12 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression |
scientific article published on 12 March 2020 |
Statements
Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression (English)
Fang Liu
Aifang Xu
Yan Zhang
Weiling Xuan
Tingbo Yan
Kenv Pan
Wenyan Yu
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference